Attention AACR-NCI-EORTC Molecular Targets Conference Registrants - Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Molecular Marker Driven Trial Design (Educational Session)

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3
Statistical Issues in Identifying, Validating and Using Molecular Markers in Clinical Trials
Marc E. Buyse, Sc.D.
International Drug Development Institute, Ottignies, Belgium
from 2008 Molecular Diagnostics in Cancer Therapeutic Development conference on September 22, 2008 4:30 PM-6:30 PM
Multiple Markers-the FDA Perspective
Steven I. Gutman, M.D.
Food and Drug Administration, Rockville, MD
from 2008 Molecular Diagnostics in Cancer Therapeutic Development conference on September 22, 2008 4:30 PM-6:30 PM
Molecular Marker Driven Trial Design
Donald A. Berry, Ph.D.
UT M.D. Anderson Cancer Center, Houston, TX
from 2008 Molecular Diagnostics in Cancer Therapeutic Development conference on September 22, 2008 4:30 PM-6:30 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3